| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. | General Counsel and Corp Sec | Stock Option (right to buy) | 63,589 | 31 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CTNM | Contineum Therapeutics, Inc. | 31 Jan 2025 | 1 | $0 | 4 | General Counsel and Corp Sec | 31 Jan 2025, 16:41 |
| CTNM | Contineum Therapeutics, Inc. | 03 Jun 2024 | 1 | $0 | 4 | General Counsel and Corp Sec | 03 Jun 2024, 17:46 |
| CTNM | Contineum Therapeutics, Inc. | 30 May 2024 | 0 | $0 | 3 | General Counsel and Corp Sec | 03 Jun 2024, 17:43 |
| TYRA | Tyra Biosciences, Inc. | 01 Mar 2022 | 0 | $0 | 3 | General Counsel and Secretary | 03 Mar 2022, 17:39 |